I-Latisse evunyelwe i-FDA yiyona ndlela yokukhethwa kwe-eyelash okubangelwa yi-chemotherapy
Kulabo abaye balahlekelwa ama-eyelashes ku-chemotherapy , isidakamizwa esibizwa ngokuthi i- Latisse , igama lokuhweba nge-bimatoprost, lingase libe yisisombululo sokuphindwa kwemali . Isidakamizwa somuthi yilapho sokuqala ukuvunyelwa yi-FDA ngokukhula kwe-eyelash nokunyamaza. Nakuba i-Latisse ingathengiswa ngokukhethekile kubantu abanomdlavuza, kungenzeka kube ukwelashwa kokulahlekelwa kwe-eyelash noma ukunciphisa okubangelwa yi- chemotherapy .
Kubalulekile ukuqaphela ukuthi uLatisse ayizange ihlolwe ngokugcwele kulabo abane-eyelash eyelash loss-induced insect. Imiphumela emibi ephathelene nabantu abaphathwa ukwelashwa aziwa. Buza i-oncologist yakho uma i-Latisse ikulungele wena, noma uma usuqedile ukwelashwa, qiniseka ukuthi udokotela obekayo uyazi ngemithi yakho yangaphambili.
Usebenzisa kanjani i-Latisse?
I-Latisse yindlela yokwelapha eyasetshenziswa ezisekelweni ze-eyelashes kusihlwa kusihlwa. Ngaphambi kokuyisebenzisa, kufanele ususe kuqala okokuzilungisa nokuxhumana kwama-lens. I-Latisse ihlanganiswe njengethikithi enebhola encane lesisombululo kanye nabafakizicelo ababukeka njengama-bluebrushes amancane. Cindezela ihlumela elilodwa lesisombululo kwisiphakamiso se-applicator bese ufaka ngaphansi kwemivimbo. Isixazululo esiningi ngokweqile ngamathambo futhi ulahle umfakisicelo. Ukuvimbela ukungcola okuphambene kwamabhaktheriya, kufanele njalo usebenzise i-applicator entsha iso ngalinye.
Kude Kanjani Ngaphambi Kokubona Ukukhula Kwama-Eyelash neLatisse
Iningi labantu liqala ukubona imiphumela yokuqala emasontweni angu-8 ngemuva kwesicelo sokuqala.
Imiphumela egcwele ingalindelwa emavikini angu-12 kuya kwangu-16. ULatisse uphumelele ekuvivinyweni kwemitholampilo, nge-78% yabathintekayo abanokukhula okuphawulekayo kokukhula, ukuqina nokukhanya.
Imiphumela emibi ye-Latisse
Ukubomvu kwamehlo nokukhwabanisa kuwumphumela ovame kakhulu wokusebenzisa i-Latisse. Ukusebenzisa kahle umkhiqizo kunganciphisa imiphumela emibi.
Ngesikhathi uvivinywe lwezokwelapha, lemiphumela emibi yanciphisa ukusetshenziswa.
I-Latisse ingabangela futhi ukuthi i-hyperpigmentation yesikhumba. Ukuguqulwa komzimba kuyimvelo lapho inani elinyuka le-melanin likhona esikhumbeni, liveza amabala anjenge-freckle-like. Akulimazi futhi ezimweni eziningi, okwesikhashana. Futhi, ukulandela izikhombisi-ndlela zokufaka isicelo kuzonciphisa kakhulu ingozi yokuguqula igazi. Uma i-Latisse ishiywe, ngokuvamile ukuguqulwa kwama-hyperpigmentation kuyahamba. Kodwa-ke, udokotela wakho angakwazi ukunikeza i-static steroid uma kudingeka.
Ngenxa yokuthi izithako kuLatisse nazo zisetshenziselwa ukwelashwa kwe-glaucoma, kunengozi engavamile ukuthi iris yamehlo ingase ihlakulele i-pigmentation ensundu. (Lo mphumela ohlangothini awuzange ubonwe kunoma yikuphi ukuvivinywa komtholampilo, kodwa kungenzeka kube yinto engavamile.)
Ingabe Umshuwalense Wami Uzovala Latisse?
Izinkampani zomshuwalense zibona uLatisse imithi yokwelapha, hhayi ukwelashwa. Ikhamphani yakho yomshuwalense kungenzeka noma ingayikufihla uma ulahlekelwe i-eyelashes yakho ekhemotherapy. Kungathatha incwadi eningiliziwe evela kudokotela wakho echaza ukuthi kungani lokhu ku-Latisse kunesidingo sempilo. Lesi simo sifana nezinkampani zomshuwalense ezifaka izindleko zezinwele zezinwele kanye nama-wigs for iziguli zomdlavuza.
Kungathatha izinhlamvu eziningi namakholi wefoni ukuze umhlinzeki wakho akhokhe i-Latisse.
Uma ukhetha ukuya emgwaqweni ongaphandle kwe-pocket, izindleko ze-Latisse cishe ngama-$ 4 ngosuku. Lokho kufana ne $ 450 kwenkambo yokwelapha yeviki engu-16. Ukuze ulondoloze ukukhula kwe-lash, kumele usebenzise uLatisse cishe kabili ngesonto. Uma sekuqedile, izibhamu zibuyela esimweni sazo esivamile.
Imithombo:
I-Allergan. I-Lattise: Okumele Ukulindele
I-American Cancer Society. Yiziphi Imiphumela Ezingenzeka Ezingenzeka Ze-Chemotherapy? Agasti 8, 2008.
UCarrie L Morris, u-SS Stinnett noJA Woodward. "Indima ye-Bimatoprost Eyelash Gel ekwenzeni i-Chemotherapy-induced Madarosis: Ukuhlaziywa kobuciko nokuphepha," Int J Trichology . 2011 Jul-Dec; 3 (2): 84-91. doi: 10.4103 / 0974-7753.90809.